GRI Report

The report describes Sartorius's contribution to worldwide COVID-19 vaccine projects and its role in developing biopharmaceutical medicines. It reports a target to reduce direct and bought-in-energy emissions by around 45% by 2030 versus 2019. It also highlights completion of the Sartorius plastics strategy and initial implementation across the operational divisions.